Drug Type CAR-T |
Synonyms C3M-CAR-T(Yonsei University) |
Target |
Action inhibitors |
Mechanism CLDN3 inhibitors(claudin 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
EGFR-mutated non-small Cell Lung Cancer | Preclinical | South Korea | 29 Apr 2025 |